X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2571) 2571
Newspaper Article (418) 418
Publication (290) 290
Book Chapter (60) 60
Book Review (36) 36
Book / eBook (14) 14
Dissertation (9) 9
Web Resource (6) 6
Conference Proceeding (5) 5
Magazine Article (5) 5
Trade Publication Article (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cannabidiol (2280) 2280
index medicus (1076) 1076
humans (961) 961
animals (910) 910
male (745) 745
cannabinoids (743) 743
pharmacology & pharmacy (700) 700
cannabidiol - pharmacology (666) 666
marijuana (561) 561
cannabis (522) 522
neurosciences (461) 461
mice (442) 442
tetrahydrocannabinol (391) 391
rats (366) 366
female (339) 339
cannabidiol - therapeutic use (304) 304
clinical neurology (301) 301
dronabinol - pharmacology (295) 295
psychiatry (281) 281
cannabinoids - pharmacology (268) 268
delta-9-tetrahydrocannabinol (258) 258
delta-tetrahydrocannabinol (244) 244
epilepsy (234) 234
endocannabinoid system (219) 219
analysis (216) 216
dose-response relationship, drug (214) 214
pharmacology (209) 209
adult (208) 208
medical marijuana (196) 196
thc (196) 196
cannabidiol - administration & dosage (190) 190
cannabinoid (189) 189
drug combinations (176) 176
anandamide (153) 153
pain (149) 149
multiple sclerosis (146) 146
disease models, animal (142) 142
hemp (139) 139
cannabinoids - therapeutic use (137) 137
cbd (137) 137
research (137) 137
biochemistry & molecular biology (135) 135
receptors (135) 135
anxiety (134) 134
inflammation (134) 134
middle aged (134) 134
dronabinol (133) 133
health aspects (133) 133
cannabis - chemistry (130) 130
neurology (129) 129
schizophrenia (129) 129
brain (126) 126
care and treatment (126) 126
receptor (124) 124
expression (122) 122
cannabinoid receptor (121) 121
treatment outcome (121) 121
cannabinoid receptors (120) 120
double-blind (119) 119
seizures (118) 118
time factors (117) 117
in-vitro (113) 113
dronabinol - therapeutic use (112) 112
endocannabinoids (112) 112
activation (107) 107
oxidative stress (107) 107
plant extracts - therapeutic use (107) 107
article (106) 106
multiple sclerosis - drug therapy (105) 105
dronabinol - administration & dosage (104) 104
multiple-sclerosis (104) 104
drug therapy (101) 101
spasticity (100) 100
rats, wistar (99) 99
cannabinol (95) 95
drug interactions (95) 95
inhibition (95) 95
dronabinol - analogs & derivatives (93) 93
cancer (92) 92
clinical trials (92) 92
psychosis (92) 92
drugs (91) 91
behavioral sciences (88) 88
mental disorders (88) 88
muscle spasticity - drug therapy (88) 88
apoptosis (87) 87
cb1 (87) 87
neuroprotection (87) 87
double-blind method (86) 86
usage (86) 86
rat (85) 85
cannabidiol - analysis (84) 84
δ9-tetrahydrocannabinol (84) 84
adolescent (83) 83
dronabinol - analysis (83) 83
brain - drug effects (82) 82
cannabidiol - adverse effects (82) 82
young adult (82) 82
medicine (81) 81
pharmacokinetics (80) 80
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2864) 2864
Spanish (117) 117
German (30) 30
French (20) 20
Japanese (12) 12
Chinese (9) 9
Portuguese (8) 8
Hungarian (4) 4
Danish (3) 3
Polish (3) 3
Italian (2) 2
Norwegian (2) 2
Korean (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Trends in Pharmacological Sciences, ISSN 0165-6147, 2016, Volume 38, Issue 3, pp. 198 - 201
Once a widely ignored phytocannabinoid, cannabidiol now attracts great therapeutic interest, especially in epilepsy and cancer. As with many rising trends,... 
Advanced Basic Science | PHARMACOLOGY & PHARMACY | DELTA-9-TETRAHYDROCANNABINOL | THC | Cannabis - chemistry | Humans | Cannabidiol - pharmacology | Cannabidiol - therapeutic use | Cannabis - metabolism | Cannabidiol - metabolism | Cannabidiol - chemistry
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 04/2019, Volume 368, pp. 63 - 71
Cannabidiol (CBD) is a natural compound with psychoactive therapeutic properties well described. Conversely, the immunological effects of CBD are still poorly... 
Cannabidiol | DHM-Cannabidiol | Macrophages | TNF | NF-kB
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 04/2019, Volume 368, pp. 63 - 71
Cannabidiol (CBD) is a natural compound with psychoactive therapeutic properties well described. Conversely, the immunological effects of CBD are still poorly... 
Cannabidiol | DHM-Cannabidiol | Macrophages | TNF | NF-kB
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2016, Volume 15, Issue 3, pp. 270 - 278
Journal Article
NEUROPHARMACOLOGY, ISSN 0028-3908, 08/2013, Volume 71, pp. 282 - 291
The mechanisms underlying the neuroprotective effects of cannabidiol (CBD) were studied in vivo using a hypoxic-ischemic (HI) brain injury model in newborn... 
Pigs | Brain | Neuroprotection | ACTIVATION | Serotonin | PIGLET | Cannabidiol | REPERFUSION | BLOOD-FLOW | NEUROSCIENCES | ENCEPHALOPATHY | HETEROMERS | Cannabinoids | IN-VITRO | Newborn | TARGETS | PHARMACOLOGY & PHARMACY | CEREBRAL-ISCHEMIA | Hypoxia-ischemia | Neuroprotective Agents - therapeutic use | Neurons - pathology | Serotonin 5-HT1 Receptor Antagonists - pharmacology | Humans | Neuroprotective Agents - antagonists & inhibitors | Protein Multimerization | Receptor, Serotonin, 5-HT1A - genetics | Male | Cannabidiol - antagonists & inhibitors | Hypoxia-Ischemia, Brain - pathology | Receptor, Cannabinoid, CB2 - antagonists & inhibitors | Brain Injuries - physiopathology | Receptor, Cannabinoid, CB2 - genetics | Recombinant Fusion Proteins - metabolism | Brain - metabolism | Cannabinoids - pharmacokinetics | Hypoxia-Ischemia, Brain - etiology | Neuroprotective Agents - pharmacology | Neuroprotective Agents - pharmacokinetics | HEK293 Cells | Cannabinoid Receptor Antagonists - pharmacology | Cannabidiol - pharmacokinetics | Cannabidiol - therapeutic use | Neurons - metabolism | Neurons - drug effects | Cannabinoids - metabolism | Hypoxia-Ischemia, Brain - metabolism | Receptor, Serotonin, 5-HT1A - metabolism | Disease Models, Animal | Animals, Newborn | Nerve Tissue Proteins - antagonists & inhibitors | Hypoxia-Ischemia, Brain - drug therapy | Neurons - immunology | Cannabidiol - pharmacology | Random Allocation | Brain - drug effects | Nerve Tissue Proteins - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Cannabinoids - therapeutic use | Animals | Receptor, Serotonin, 5-HT1A - chemistry | Reperfusion Injury - prevention & control | Brain - pathology | Brain - immunology | Sus scrofa
Journal Article
Journal of Pain and Symptom Management, ISSN 0885-3924, 2010, Volume 39, Issue 2, pp. 167 - 179
Journal Article
Journal Article